MEDICAL PROFESSIONALS

Disease State

Increased understanding of the pathophysiology of Afib guiding new treatment approaches

 

Factors responsible for the onset of Afib include triggers that induce the arrhythmia and the substrate that sustains it [reviewed in (ref. 13)]. While pharmacological approaches attempt to control cardiac rate or rhythm, they do not directly address the source of the arrhythmia and thus may have only limited efficacy in preventing recurrence. In this regard, newer therapeutic approaches such as catheter ablation focus directly on the elimination of ectopic sources and reentrant pathways. Understanding more about these aberrant foci and pathways will allow for more effective ablative approaches.


 

ectopic foci and single/multiple circuit re-entries with ablation lesions

Figure: ectopic foci and single/multiple circuit re-entries with ablation lesions.

 

©Johnson & Johnson Medical NV/SA, 2010. Last update on:03 Feb 2012 This site is published by Johnson & Johnson Medical NV/SA, which is solely responsible for its contents. This section of the website is intended for visitors from the European Economic Area (EEA), excluding France. The EEA includes the 25 EU member states and Norway, Iceland, and Liechtenstein. Capitalized product names are trademarks of Biosense Webster.